BASEL, Switzerland, Aug-28-2017 — /EuropaWire/ — Global brand leader Invacare brings next generation technology to powerchairs, following extensive trials and consumer-led insights. Touch screen technology is used daily on devices such as smartphones and tablets and thanks to Invacare, this smart technology has now been encompassed into powerchairs.
The innovative REM400 remote has an impressive 3.5” colour touch screen that puts the user in complete control. Its features include:
• Swipe or tap operation
• Direct or menu navigation access to profiles and functions
• Adjustable brightness
• Glove mode setting
• Screen lock out function
• Configured for left or right handed use
And it doesn’t end there. The REM400 has built-in Bluetooth which allows connection to PC’s, laptops and Macs. Its integrated mouse mover with on screen mouse clicks lets users connect to their world through their remote.
One of the great benefits of a touch screen remote is that there are no fixed buttons. This makes the REM400 suitable for those with more complex physical and cognitive needs.
To see the REM400 in action, checkout the new video.
CARDIFF, United Kingdom, Aug-24-Aug-2017 — /EuropaWire/ — Global brand leader Invacare is once again raising the bar in the powerchair market, following on from the successful launch of the LiNX control system last year. Invacare has taken the smart technology a step further with a new touch screen remote, in-built Bluetooth technology, enhanced programming features and a range of specialist controls, all available on the remarkable Invacare LiNX powerchair range.
Touch screen remote
Introducing next generation technology to powerchairs, Invacare is pleased to present the REM400 remote with its 3.5” interactive screen that requires minimal force to operate. Following extensive customer-insight research, this innovative remote can be configured to a users’ physical and cognitive ability, thanks to its extensive functional capabilities. Also available is a REM500, a display only version of the REM400. Both remotes can be used with a wide range of specialist controls.
The REM400 and REM500 controls have built-in Bluetooth technology to allow users to connect to their PC, Mac and compatible Android devices that have built-in HID functionality.
Enhanced programming features
The LiNX system now allows professionals to mix and match the drive, seating and environmental controls in order to customise the display to suit the user’s lifestyle. E.g. The profiles can be customised by names such as Home, Outdoor and Work, with functions specific to each one. Profiles can also be set by user input options i.e. head control.
Another new feature is the ability to adjust the joystick commands. The basic commands on a powerchair are forward, reverse, left and right but there are also other commands such as tilt, recline, lights, horns etc. to consider. The REM400 and REM500 allow these commands to be changed to suit the user, based on frequency or even by accessibility.
To maximise a user’s control and independence, the REM400 and REM500 allow a selection of specialist user inputs to be used on Invacare’s remarkable powerchairs. They range from head controls, chin controls, Sip ‘n’ puff systems, joystick options, proximity switches and dual controls, allowing Invacare to provide a control solution for many powerchair users. To help professionals select the best control for a powerchair user, Invacare has put together a useful app with five simple steps to assist with the process. Take a look at the app by visiting www.linx4you.com plus it can downloaded from the Google Play Store and Apple App Store.
TDX SP2 base updates
The above offering is available on all Invacare LiNX powerchairs, with a selection of the specialist controls only compatible with the TDX SP2 Ultra Low Maxx – and it is with this chair that Invacare is now able to fully enter the complex rehab market. For more information on the TDX SP2 Ultra Low Maxx, visit www.invacareULM.com. As well as feature heavy, the TDX SP2 base itself can be customised thanks to the 10 contemporary shroud and rim insert options available which sit nicely on its new black tyres and castors. There is a new single sided fork option on the front and rear castors.
GERMANY, Mar-30-2017 — /EPR HEALTHCARE NEWS/ — Ulcerative colitis and Crohn’s disease are the most common inflammatory bowel diseases (IBD). Globally, more than 4 million people suffer from recurring inflammation of the intestinal mucosa. To date, non-invasive methods have not been able to detect these forms of IBD reliably. Researchers at the University Hospital Erlangen (Germany) have now shown for the first time how Multispectral Optoacoustic Tomography (MSOT) can more reliably detect early stages of inflammation when compared with other non-invasive diagnostic methods. These results have recently been published in the New England Journal of Medicine.
Evaluating the inflammatory activity of the intestines early and accurately helps to prevent complications associated with IBD and guide an optimal therapy regime. Currently, doctors frequently rely on an invasive endoscopy procedure to assess the intestinal mucosa of patients with IBD. Additionally, non-invasive imaging methods are increasingly used in the clinic. For example, ultrasound allows clinicians to examine the structure, thickness and blood perfusion of the intestinal wall with changes in perfusion patterns indicating an onset of inflammation.
“With the MSOT procedure, we additionally use laser light, by which we can detect inflammation earlier than previously possible with ultrasound”, explains Prof. Dr. Maximilian Waldner, Professor at the University Hospital Erlangen. “The earlier we detect signs of an upcoming flare – i.e., a change in blood content – the quicker we can react and start a preventive treatment”. The MSOT technology was developed by iThera Medical in Munich, and was first used on IBD patients last year.
The researchers of the University Hospital Erlangen have recently published their results in the renowned New England Journal of Medicine. “We examined 108 patients with Crohn’s disease using the MSOT technology and compared the results to established non-invasive diagnostic procedures as well as endoscopy and histology”, says Prof. Waldner. “We were able to demonstrate that hemoglobin values in the tissue measured with MSOT indicate very accurately the inflammatory activity in the intestines. The method appears to be superior to other non-invasive procedures, as MSOT for the first time was able to detect even low levels of inflammation without having to perform endoscopy”.
Dr. Ferdinand Knieling, a physician at the University Hospital Erlangen, adds: “We are hoping that this principle can be applied to many applications and, in particular, also be used to enable safe evaluations of children and adolescents. With this new examination method, many of the currently invasive procedures might become obsolete.”
In optoacoustic imaging, the physician scans the intestines transabdominally through the skin, applying pulsed laser light in the near-infrared region. The energy of the light absorbed in tissue is converted into acoustic signals which are then acquired by an ultrasound detector. Christian Wiest, CEO of iThera Medical, comments: “MSOT is a new diagnostic imaging modality that can detect changes in tissue composition associated with a variety of diseases, without the use of contrast agents. The technology has already been applied in other clinical feasibility studies, e.g. for the detection of melanoma metastasis in sentinel lymph nodes or for the assessment of suspicious breast lesions”.
The results of the IBD study at the University Hospital Erlangen were published on March 30th 2017 in the New England Journal of Medicine (Volume 376, Issue 13, pg.1292-1294).
Cambridge, England, 2017-Feb-14 — /EPR HEALTHCARE NEWS/ — Resveratrol and lycopene are the compounds known for anti-ageing and cardio-protective properties. Mediterranean diet based, among others, on consumption of big quantities of lycopene-rich vegetables coincides with a longer lifespan, lower incidence of CVDs and reduced occurrence of some forms of cancer among the population of Mediterranean region. High resveratrol consumption is considered a factor in “French Paradox”, where epidemiological data show low incidence of CVDs, despite high consumption of saturated fats. Consumers have enormous choice of food supplements including lycopene and resveratrol, but key information is often missing: what happens to the substance once consumed and how much of it is really absorbed?
Resveratrol – the powerful anti-ageing, antioxidant polyphenol
Resveratrol is a phytochemical from polyphenols family, compounds known for their antioxidant properties. It is produced by plants in response to different stresses from their surrounding environment and found mainly in the peel and seeds of red grapes, also in peanuts and berries. High resveratrol consumption is considered a factor in “French Paradox”, where epidemiological data show apparent disconnect between the incidence of cardiovascular diseases in French population and high consumption of saturated fats. It is thought to be related to high consumption of red wine that contains resveratrol. There is significant scientific research on the beneficial effects of resveratrol relating to anti-ageing and longevity – activation of sirtuin enzymes, support of mitochondrial metabolism, protection of telomeres, antioxidant properties. It also supports cardiovascular health and influences glucose metabolism management.
Lycopene – great contributor to healthy skin
Lycopene belongs to family of plant-derived substances – carotenoids. Due to their strong antioxidative properties carotenoids help protect plants from oxidative damage caused by various stressing factors. Scientific interest in lycopene originates from the phenomenon of the Mediterranean diet and its’ cardio-protective and longevity promoting properties. The Mediterranean diet is based, among others, on high consumption of tomatoes and other vegetables that contain high levels of lycopene and other carotenoids. The population of the Mediterranean region has a longer lifespan, lower incidence of cardiovascular diseases and lower occurrence of some forms of cancer. Because of its’ antioxidative properties lycopene helps fight against free radicals in the skin, reduces its’ sensitivity to UV radiation, reduces mitochondrial DNA damage, lowers the risk of heart diseases.
Carocelle® presents best in class lycopene and resveratrol anti-ageing supplement
The main challenge of resveratrol supplementation remains its’ bioavailability. As quickly as it is absorbed from intestinal tract to bloodstream most of it is transformed into inactive compounds. New Carocelle® Lycopene & Resveratrol formulation delivers superior bioavailability, proven in clinical trials. Carocelle® technology makes resveratrol over +500% more bioavailable than other products on the market and provides its’ outstanding concentration that would normally be difficult to obtain from other available sources.
Pharmacokinetic tests for Carocelle® Lycopene have also confirmed 2x higher concentration of lycopene in the bloodstream (bioavailability) in comparison to reference brand available on the market, with the same dosage of the compound.
Carocelle® Technology behind compounds’ superior bioavailability
Vesicle-micellisation helps carotenoids become more resistant to degradation in the highly acidic stomach environment. This ensures that more active lycopene and resveratrol can pass to the intestines and be absorbed. The vesicle-micelle format is easily transformed in the intestines by bile acids to the mixed micelles. This guarantees optimal absorption of fat-soluble ingredients, like lycopene and resveratrol. The result is increased delivery of active lycopene and resveratrol to the intestine for maximum absorption, improved bioavailability and remarkable bioactivity. Chaperone compounds in Carocelle® Lycopene & Resveratrol vesicle-micelles additionally contribute to increased bioavailability of both lycopene and resveratrol.
There are currently 3 SKUs within Carocelle® range:
Carocelle Cambridge Micelle Technology™ was founded in 2015 in collaboration with UK biotech firm Lycotec, headed by Dr. Ivan Petyaev. The company invents proprietary formulations and products that are scientifically tested and proven in laboratories in Cambridge, UK. Carocelle Cambridge Micelle Technology™ has its headquarters in Cambridge and operates a network of partnerships with research and commercial partners around the world.
DR. IVAN MIKHAILOVICH PETYAEV, MD, PHD
Dr. Petyaev is a medical doctor, researcher and author of scientific publications and inventions with applications in diagnostics, analytics, prevention and treatment of a variety of diseases. He spent his research years at MRS and Cambridge University in the Department of Pathology. To take his discoveries into innovative healthcare products he left University and set up his own company, Lycotec Limited. Dr Petyaev has wide experience of driving his innovations through the product development phase, clinical validation and in the setting up of industrial production of the successful prototypes. His projects have been supported by Cambridge University, the MRC, Papworth and Addenbrooke’s Hospitals, the British Heart Foundation, the Department for Trade and Industry and the Eurostars Eurica Project.
Vilnius/Lithuania, 2016-Oct-18 — /EPR Healthcare News/ — ZIVE smart radiation monitor has reached the final of Elektra Awards 2016, a big influential contest for the electronics market players. This device designed by R-NOX startup with the assistance of Promwad Electronics Design House was named one of six best innovative products of Europe exploiting the Internet of Things potentialities.
ZIVE is a portable radiation monitor of the next generation that can connect to smartphones and tablets via Bluetooth. It’s the first device of professional level designed for common people. It has a user-friendly interface, a Geiger-Muller counter, and a low market price comparing with other high-precision radiation monitors.
ZIVE radiation monitor measures gamma rays, ionizing radiation, and X-rays. Differentiating features of the device:
Calibrated by accredited European laboratories (CE).
High accuracy at a lower price in comparison with other similar devices.
“Smart monitor” mode that provides users with specific health and well-being advice: how to interpret the measurements and reduce the risks.
Working with maps to create eco-routes: save radiation spots, find cleaner routes.
The collected ZIVE data is used for the real-time global map of radiation contamination.
Roman Pakholkov, Promwad’s CEO and R-NOX’s mentor, says that the data collected by ZIVE users is stored in the eco-platform, which is becoming the most detailed in the world. This platform allows accelerating the innovations development for the environmental management and can be integrated into other devices and applications via the open API.
To date, R-NOX has developed partnerships with the largest tour operator in the Chernobyl Nuclear Power Plant Zone of Alienation; Greenpeace; companies and organizations in Japan, Finland, Singapore, and other countries.
Promwad continues its work in supporting new electronics design projects in the IoT field. The company believes in the high potential of this popular trend and are ready to share their experience in the development and manufacture of electronic products for the global consumer electronics market.
The best companies of Elektra Awards 2016 will be announced on Thursday, 1st December, at the awards ceremony taking place in The Ballroom, Grosvenor House Hotel, London.
+370 (5) 214 12 44 ex.227
Systech will be part of Sharp’s panel discussion addressing delegates on the theme of “Serialization: Optimizing Your Supply Chain Means Optimizing Your Partners.” The presentation will explore the critical path to supply chain readiness, risk assessment, benchmarking and serialization risk mitigation options. The briefing will take place in the Pharma Insight Briefing room on Tuesday, 4 October 2016 at 11:30am CEST.
Systech will also showcase its UniSeries™ serialization software offered as an integrated solution within Autajon’s exhibit booth #2P16 (Hall 2).
CPhI Worldwide, together with co-located events ICSE, InnoPack, P-MEC and FDF, will host more than 36,000 visiting pharma professionals from 4-6 October at the Fira Gran Via, Barcelona, Spain. More than 2,500 exhibitors from 150+ countries gather at the event to network and take advantage of more than 100 free industry seminars. Every sector of the pharmaceutical market is represented under one roof, this year in a new location in Barcelona.
With thousands of implementations across the globe, Systech is the world’s most trusted brand protection expert, and its UniSeries offering is the industry standard for serializing products. UniSeries is offered as an integrated solution with both Sharp Packaging and Autajon Group’s hardware. Systech’s patented, configurable software offers manufacturers the flexibility to adapt to new regulations without extensive reworking or revalidation, thereby reducing implementation, training and support costs.
“We are recognized as the world leader in serialization and brand protection,” states Manfred Voglmaier, Senior Director Sales Europe, Systech International. “With more than 30 years of experience in providing highly configurable solutions for serialization across a variety of industries ― along with our partners Sharp Packaging and Sinel ― gives us a unique insight for this panel.”
Systech’s products are in greater demand than ever before since it is estimated that over 15,000 production lines for prescription medication in Europe must be fitted with a serialization system over the next three years. The European Commission adopted a regulation on October 2, 2015, under which the serialization of prescription medicine packages will become mandatory in all EU countries by 2019.
Show exhibit hours are on Tuesday, 4 October – Thursday, 6 October. Systech representatives will be available in the Sharp Packaging booth #3L56 (Hall 3) during the event, as well as in the Autajon booth #2P16 (Hall 2). They will showcase Systech’s software solutions on sample packaging lines and via live demos throughout the event.
Join The Anniversary Celebration of the Fastest-Growing Organization In The Cannabis Industry
Santa Rosa, CA, 2016-Jun-17 — /EPR HEALTHCARE NEWS/ — It has been 20 years since California pioneered the nation in legalizing medical cannabis with Prop 215. Now California makes up 49 percent of the nation’s robust cannabis economy. California’s cannabis scene has exploded like the Wild West and there’s one more reason to celebrate. Sonoma County’s Canna-enthusiasts are invited to join Women Grow to mark its 1-year Anniversary with a celebration and award ceremony to honor ‘The Godmother of Cannabis’, Lynnette Shaw.
Women Grow is a national organization that seeks to connect and empower women in the legal cannabis industry and the group’s Sonoma County Chapter is excited to share their achievements. In the past year, the Chapter brought in 23 industry leader speakers and panelists, of whom 21 were women and 2 were men. Speakers have included: Amanda Reiman, Manager of Marijuana Law and Policy at Drug Policy Alliance, Samantha Miller, President and Chief Scientist at Pure Analytics, Ellen Komp, Deputy Director at California NORML and Jazmin Hupp Co-Founder/CEO of Women Grow.
“The cannabis industry’s future is held in our hands,” says Chapter Founder and Chairwoman, Ilana ‘Sugar’ Laytart. “We are currently writing the history and HER-story books and this event’s celebration is to acknowledge our commitment and perseverance in this movement.”
The celebration takes place on Thursday, July 7, from 6pm to 10pm at Annie O’s Music Hall in downtown Santa Rosa. “Celebration Attire” is suggested. Early-bird tickets cost $25 and can be purchased through Universe.com.
When: Thursday, July 7th, 6pm-10pm Where: Annie O’s, 120 5th Street, Santa Rosa Cost: EARLY BIRD $25
DOOR $40 CASH ONLY Event Highlights:
Terpenes 101 + Aroma Bar Presentation with Monica Fine of Absorb CBD and The Seasonal Apothecary.
Award Ceremony Honoring Lynnette Shaw, presented by Ilana ‘Sugar’ Laytart and Elaine Holtz.
Dessert Bar, DJs & Dancing, Giveaways, Snacks & Beverages and Cash Bar
Interested in being a sponsor? Email firstname.lastname@example.org
Financial assistance may be available. Email email@example.com to inquire.
This is a 21+ event and a non-consumption event.
Women Grow connects, educates, inspires and empowers the next generation of cannabis industry leaders by creating programs, community and events for aspiring and current business executives in the cannabis industry. Women Grow is the fastest “growing” network of female-forward cannabis businesses and the largest networking organization in the cannabis industry. You don’t have to be a current professional in the cannabis industry to join. The Sonoma County Chapter is run by Founder and Chairwoman Ilana ‘Sugar’ Laytart and Co-Chair: Joyce Williams.
While events are women focused, their networking series welcome and attracts both men and women to connect. Women Grow Networking Events occur the first Thursday of every month in Sonoma County. Website: www.womengrow.com.
Contact-Details: Nancy Birnbaum
Russian River PR
Palo Alto, CA, June 27, 2015 — /EPR HEALTHCARE NEWS/ — Kaeng Raeng, a leading creator of natural dietary supplements and cosmetics, best known for it’s 3-day Detox Cleanse program, has announced the launch of a new Amazon Ambassador program.
Amazon’s community guidelines allow for brands to provide free product or samples of products to individuals in exchange for an expectation of an Amazon review. Kaeng Raeng will accept applicants via their website to sample product offerings in expectation of ambassadors leaving Amazon reviews, which are not required to be positive-just honest.
About Kaeng Raeng
Based in Palo Alto, California, Kaeng Raeng is a leading creator of natural dietary supplements and cosmetics. Founded by certified personal trainer and Stanford alumna Lindsay Reinsmith, Kaeng Raeng is a delicious, convenient, and affordable cleanse program. For more information, visit www.kaengraeng.com or join the brand on Facebook at Facebook.com/kaengraeng.
Kaeng Raeng – Be Healthy. Be Strong.
Contact: Kelly Bronson
Kaeng Raeng Director of Marketing
Brescia, Italia, May 19, 2015 — /EPR NETWORK/ — Secondo la #SIIA (Società Italiana dell’Ipertensione Arteriosa), in Italia
• il 31% delle donne ed il 33% degli uomini soffre d’ipertensione arteriosa*
• il 14% delle donne ed il 19% degli uomini “sani” sono in una condizione di rischio**
• solo il 35% degli ipertesi trattati ha valori di pressione arteriosa normalizzati”***
• l’obbiettivo è portare, entro il 2015, il 70% della popolazione degli ipertesi alla normalizzazione dei valori di pressione arteriosa.
* Ipertesi: sono i pazienti con pressione arteriosa uguale o superiore a 140/90 mmHg..
** Condizione di rischio: quando il valore della pressione sistolica è compreso fra 140 e 160 mmHg e quello della diastolica è compreso fra 90 e 95 mmHg.
*** Secondo le Linee Guida Europee 2013 i valori di norma sono quelli inferiori a 130/85..
Le Linee Guida 2013 della Società Europea dell’#Ipertensione sottolineano che i valori di pressione arteriosa rilevati al domicilio hanno un significato prognostico maggiormente predittivo di accidenti cardiovascolari rispetto ai valori rilevati in ambulatorio.
#HTN Easy Blood Pressure è l’abbonamento annuale per il monitoraggio della pressione arteriosa, in modo semplice ed efficace.
Il servizio si basa sull’utilizzo, in alternativa, di due device per la rilevazione dei valori della pressione arteriosa:
• iHealth BP5, a trasmissione via Bluetooth
• A&D UA-767NFC, a trasmissione via NFC
L’abbonato è in grado di rilevare quante misure desidera e tutte saranno trasmesse, attraverso uno smartphone, al proprio Personal Health Record, sempre accessibile in modo sicuro, attraverso la piattaforma software proprietaria #SmartTelemedicine.
Ogni tre mesi, oppure a sua richiesta, riceverà un referto sui valori registrati.
In sintesi, l’offerta prevede:
• quattro prestazioni di refertazione specialistica dei valori pressori all’anno
• una chiamata a personale sanitario HTN all’anno
• fino a 4 Personal Health Record sulla piattaforma software SmartTelemedicine
• il comodato d’uso gratuito dell’apparecchiatura #iHealth BP5 ovvero A&D UA-767NFC
Ulteriori prestazioni di refertazione e/o teleconsulto possono essere richieste in qualsiasi momento.
Despite the great progress made in HIV/AIDS treatment, there is still an urgent need for new drugs, particularly for people who have had to abandon existing treatments due to HIV drug resistance and side effects.
The current treatment of HIV/AIDS involves the use of three or more drugs from five main general classes, used in combination. While this antiretroviral therapy (ART) has helped to reduced morbidity and mortality from AIDS, long term toxicity and the emergence and transmission of drug resistant HIV strains limit the effectiveness. Thus, despite therapy which can render this a chronic, rather than acute fatal infection, development of new drugs to prevent infection and overcome drug resistant strains, is increasingly urgent.
ViroCarb Inc. is developing a novel technology that addresses infections by drug resistant HIV strains. Developed from the identification of a new, natural resistance factor against HIV infection by scientists at SickKids and Canadian Blood Services, ViroCarb’s inhibitor works against a previously overlooked target on the virus to block HIV from entering human cells, the very first step in the infection. It works against all HIV strains.
Funds are needed to aid in moving forward to support preclinical studies; therefore ViroCarb Inc. has started an international crown funding campaign to carry out these HIV model studies needed before conducting clinical trials.
Please support this new way to block HIV.
Contact-Details: Dr. Mario Huesca
479 Simonston Boulevard.
L3T 4M4 Canada
WASHINGTON, IA, November 25, 2014 — /EPR HEALTHCARE NEWS/ — 783 million people live each day without clean water and 3.4 million die annually from a lack of pure water. To combat these staggering statistics, Washington-based nonprofit, Hays PureWater, launched a crowd-funding campaign. The money raised will fund 30 Khlor Glen technology units to purify water for 150,000 individuals. The organization hopes to raise $10,000 by December 1st.
Hosted on crowd-funding platform IndieGoGo, the project offers nine sponsorship levels. Each level includes novelty “rewards” for donors, ranging from stickers to t-shirts to a trip to Haiti. The rewards are unique, innovative and hands on, giving donors a sense of ownership in the project. For just $2,500, an investor can travel to Haiti (all inclusive) to see the life changing benefits first hand.
The Khlor Glen is a simple unit that turns salt water into chlorine. The chlorine treats infected water, removing deadly impurities and toxins in just one hour. It’s solar powered and easily used in remote areas, where clean water is most needed. “It will also impact malaria zones as it can be used as a bug repellant and protect from disease,” says founder John Hays. “Even just using the chlorine produced by the unit as a sanitizer can cut down on so many infections that the natives in these areas don’t even know exist.”
In the last eight years, Hays PureWater distributed over 4,000 purifying units around the world, changing entire communities by implementing this system. It’s proven to work. Hays builds each system with the help of a dedicated group of volunteers. Nothing is outsourced, ensuring the most effective product for the lowest cost. Now all they need is help from their community to change the lives of those in need once more.
ABOUT Hays PureWater
In 2006, after traveling around developing nations on missions trips, John Hays began to create a low cost, portable solution for water purification. John, who worked with municipal water works for over 30 years, put his experience to use and developed the Khlor Gen system. Through the years, the design and look has been changed and improved, but the mission has stayed the same. The organization exists to provide people with clean water, reaching out to them through word and deed. Eight years and 4,000 units later, that mission continues full steam ahead. For more information, logon to www.hayspurewater.com.
We are pleased to announce that Nutrit Meal Replacement is starting a Crowdtilt Campaign for its initial production run.
On the heals of the successful campaign for Soylent, Nutrit promises a meal replacement product that has been totally reimagined. Nutrit provides a complete days nutrition while helping a person avoid processed ingredients, soy, wheat, dairy, GMOs, and Dairy. Nutrit is made up of organic proteins and fats, flavored with organic cocoa. Nutrit costs less than fast food, is easier to make than instant noodles, and tastes similar to chocolate milk.
Meal replacement as an idea is a sound one. In a fast paced society, its hard to avoid problem ingredients and at the same time get the nutrition one requires to stay healthy. Its all too easy, in a pinch, to reach for something in a vending machine or fall back on take out food. To date, meal replacement products and protein concoctions offer an unmeasured nutrient value, and mostly contain ingredients that can cause inflammation. Nutrit has solved those problems by being an easy mix powder, that offers an organic, non-GMO ingredient list that mirrors RDA requirements.
Nutrits Crowdtilt campaign is primarily being undertaken to provide funds to meet our vendors initial minimum order quantities. The merits of this product stand on there own, and we feel it is important to get it out there. Nutrit can help the average person avoid problem ingredients, and control calorie intake, all while getting more complete nutrition than is afforded by a standard diet.
HD Biosciences Co., Ltd. (HDB) and E. J. Corey Institute of Biomedical Research (CIBR) announced that they have reached a risk-sharing agreement on collaborative drug discovery and development in the therapeutic areas of infectious diseases, metabolic diseases, and oncology. This joint effort will focus on both international and Chinese markets to provide innovative medicines for unmet healthcare needs. The agreement includes lead candidate selection pre-clinical development, IND filing, clinical trials, and NDA approvals. Both companies will share financial returns from any successes or products launches.
“We are delighted to enter this partnership. The collaboration will leverage HDB’s extensive capabilities in preclinical drug discovery and development, and create long term potentials for the company.” stated Xuehai Tan, Ph.D., President & CEO of HDB. “In combination of CIBR’s expertise in drug development, we are confident to deliver novel drug candidates over the next few years, and to make this partnership a success.”
“Working with HDB gives CIBR a unique opportunity to showcase its strength in innovative drug discovery and development,” said Wuyi Meng, Ph.D., President of CIBR. “This partnership further demonstrates CIBR’s commitment in the betterment of patient’s lives by bringing forward novel medicines. We will collaborate closely with HDB to accelerate the progress of our collaborative programs”
About HD Biosciences Co., Ltd.
HD Biosciences Co., Ltd. is a Shanghai-based, biology-focused preclinical drug discovery contract research organization (CRO). The company offers comprehensive service platforms around target validation, plate-based pharmacology, hit identification and lead discovery, therapeutic antibody discovery, in vivo pharmacology, as well as other research and development services. The company currently collaborates with eight of the ten largest pharmaceutical companies in the world and has established strategic partnerships on many key R&D areas with impacts to their portfolios. The strong scientific expertise, high quality and consistency in deliveries, constantly meeting or exceeding expectations, has earned the company a great reputation in the industry, and helped the company to build its widely recognized leadership in preclinical contract research services.http://www.hdbiosciences.com
About E. J. Corey Institute of Biomedical Research
Located in the Jiangyin High-tech Industry Development Zone in Jiangyin, Jiangsu, E. J. Corey Institute of Biomedical Research (CIBR) is a non-profit research organization founded by Nobel laureate Prof. E. J. Corey with the support from Jiangyin and Jiangsu government. CIBR is committed to scientific research in the broad biomedical field and to the development of novel therapeutics to meet the unmet medical needs of patients. In addition to its strong internal research and discovery capabilities in biomedical research and drug discovery, CIBR has established solid external capabilities in translational medicine and molecular toxicology to support drug development. Under the guidance of Nobel laureate Prof. Corey, CIBR is well poised to contribute to the discovery and development of novel medicines. http://www.cibrnobel.org
Ms. Jessie Yang
Purify Your Body, LLC (www.purifyyourbody.com) is pleased to announce that they are now accepting Bitcoin as payment for their high quality detox foot pads. By offering Bitcoin as an method of payment, Purify Your Body feels they will be able to increase their business appeal to users who are embracing this new crypto-currency exchange.
Purify Your Body offers the highest quality detox foot pads on the market, using no fillers and only natural and organic raw materials. The foot pads are most commonly used on your feet when you sleep, while the ingredients pull impurities and toxins out via your lymphatic system. In the morning, you remove the pads from your feet and discard them. Purify Your Body detox foot pads have been known to make a difference for those with fibromyalgia, inflammation, joint pain, chronic illnesses, migraines, and more. They are especially great for detoxifying heavy metals from your body. Visit their website at www.purifyyourbody.com or their Facebook page at www.facebook.com/detoxfootpads
As Bitcoin continues to increase in its popularity worldwide, Purify Your Body wants to jump into this emerging market.
Rebecca Hauptman, owner of Purify Your Body, says “Bitcoin is only going to be getting more and more popular in the future. If you are a small business like Purify Your Body, you don’t want to miss this boat. By entering the Bitcoin economy, we feel we are on our way to increasing our customer base and growing our business.”
More and more merchants online are starting to accept Bitcoin, and with its increase in value and popularity, this is the way to go.
Canopy Valley, LLC, is proud to announce the release of the LUXES, a revolutionary bracelet designed to alert the wearer they have been in the sun too long and have been exposed to excessive, and potentially damaging, ultraviolet rays.
This breakthrough tool in the fight against skin cancer couldn’t have come at a better time. A colorful bracelet makes LUXES fashionable, but it’s the UV-activated insert — made of a patent-pending smart material that simulates human skin — that makes it functional. When used properly, the bracelet changes color to signal the wearer either apply sunscreen or get out of the sun.
Inventor Gary Wong designed LUXES’ logo to pay homage to friends and family members who give him the motivation to continue the fight against skin cancer. When looking at the U and the top part of the X in the name Luxes, it spells out UV, which is what everyone needs to be aware of. Lux (symbol: lx) stands for the SI unit of both illuminance and luminous emittance, which measure luminous flux per unit area. Great care was put into the name and the design of this new product.
In addition to the bracelet, Canopy Valley’s website (http://canopyvalley.com) features engaging content, sun safety tips, and personal stories from people touched by skin cancer.
Canopy Valley was started in 2012 and is located in Milipitas, CA. They would be happy to share more information about LUXES and the fight against skin cancer to anyone interested.
HD Biosciences Co., Ltd (HDB) and Anchor Therapeutics, Inc. today announced that they have formed a strategic collaboration to co-develop and co-market Anchor’s proprietary pepducin technology and provide novel drug development solutions to global pharmaceutical companies with drug discovery efforts focused on G-protein coupled receptors (GPCR).
Pepducins are proprietary lipidated peptide modulators for GPCR signaling. They may stabilize receptor conformation, promote or inhibit dimerization, and modulate interaction of GPCR with signalosome. As a strong research tool, pepducin technology enables high throughput screening (HTS) campaigns for the identification of special class of compounds and allosteric ligands, facilitates biophysical studies via stabilization of GPCRs in different activation states and functionally de-orphanizes GPCRs to provide tools for interrogation of pharmacology in vitro and in vivo.
As a key component of HDB’s plate-based pharmacology service capabilities, GPCR assays and screenings is one of the most active research and development areas that attracts global clients and partners in drug discoveries. With over 200 recombinant GPCR cell lines in house, some of which are orphan receptors, combining a variety assay formats with pepducin technology allows HDB to enhance its capabilities for supporting hit identification, lead discovery and receptor selectivity profiling. The collaboration is also designed to provide broader exposure and accessibility of pepducin technology across pharmaceutical and biotechnology industries through HDB’s global client base. HDB’s clients will gain unprecedented access to not only the pepducin screening platform but also HDB-Anchor’s joint expertise in GPCR research.
“Anchor’s pepducin technology has provided a novel approach to search very special GPCR related compounds that have potential to alter the receptor functions. We believe this technology will be very valuable in GPCR related drug discovery.” commented Dr. Xuehai Tan, President and Chief Executive Officer of HDB. “As one of the global leaders in biology focused contract research services, HDB emphasizes on innovative and scientific driven technologies in order to deliver extra value to our clients. The partnership between HDB and Anchor is a perfect example to demonstrate our commitment to grow the expertise and strengthen our leadership in GPCR R&D.” Dr. Tan continues his comments.
“Anchor Therapeutics is extremely pleased to partner its pepducin technology with HD Biosciences, one of the leading companies providing state of the art high throughput screening services to pharmaceutical and biotechnology clients,” said Thomas J. McMurry, PhD, Anchor’s Interim President. Dr. McMurry continued, “Through this collaboration, Anchor and HDB will expand the validation of pepducin high throughput screening probes in order to provide HDB’s clients with access to innovative screens designed to facilitate access to novel small molecule pharmacophores.”
Dynamic Life Nutrition is pleased to announce the redesign of their website which features a wealth of information for health-conscious consumers who are looking for vitamins, nutritional supplements, nutraceuticals, smart pills or nootropics all through one online vitamin store.
Each newly redesigned product page on this online discount vitamins website has a thorough explanation about the product, including information on its ingredients, the benefits it will produce and which people should consider taking the vitamin as a part of a well-balanced diet. Nutrition labels for each product are provided and feature an enlarged image of the actual label so that customers can see exactly what the supplement contains. Many of the product pages include a custom created video which gives a brief introduction to the products, and customer reviews are provided as well.
In addition to the new site, Dynamic Life Nutrition is rolling out a new autoship program which allows customers to have their supplements sent to their homes or offices, in unmarked boxes for added privacy, at their desired frequency. Shipping is done on-time, making it a natural choice for people to choose when they want to buy vitamins online. This autoship vitamins program offers discounts and customers are able to cancel at any time, without pressure. With the addition of advanced analytics, customers can track their past purchases and monitor new ones to ensure that they don’t over- or under-order their favorite products. Customers can also use this new feature to track and cancel their shipments.
Healthcare Outcomes Solutions (HOS), a company dedicated to reducing health care costs for self insured companies and their employees, recently launched its Patient Centered Enhanced Care model (PCEC). PCEC is a care coordination model designed to improve health care and reduce costs specifically for employee-patients, or their family members, with multiple chronic illnesses who are in a health plan offered by self-funded companies.
It is now common knowledge that approximately 5% of members of health plans account for about 50% of the cost. Multiple chronic diseases are the source of the majority of the cost in healthcare. The PCEC model enables self-funded businesses across the U.S. to offer coordinated care specifically for these member-patients. This service is offered to middle size or larger employers.
The PCEC model has been developed by healthcare experts and is grounded in extensive research of evidence-based and outcomes studies, many of which are available on the HOS website, www.healthcareoutcomes.net. The latest data on healthcare costs show that care coordination of the most chronically ill member-patients can reduce a company’s healthcare costs significantly.
We will work with companies to determine if the PCEC model is right for them. Affiliated healthcare accountants will examine a company’s current health care expenses, and HOS will determine the feasibility of reducing cost while improving care.
Evaps introduces the world renowned electronic cigarette, the Joyetech. Cigarette smoking is a dangerous and a bad habit which can be life threatening. Therefore, Evaps takes its best foot forward to offer several types of Joyetech e cigarette which keeps the smokers satisfied and doesn’t affect their health as well. The Joyetech electronic cigarette is offered in various flavors with all the necessary accessories to keep the smokers contended without affecting their health.
Evaps.fr offers an amazing concept to help smokers cut down on smoking. The company gives Joyetech electronic cigarette which keeps the smokers contented and doesn’t affect their health as well. These cigarettes are safe to smoke in public as well, because it releases water vapor in the form of smoke which is not harmful like the regular cigarette.
Many COPD patients have been benefited by this awesome tool which helps to quit smoking. The e liquide used in Joyetech electronic cigarette is available in so many flavors that a smoker will never feel the urge to smoke the regular cigarette. Moreover, the liquid is designed in such a way that a smoker will not be able to smoke a lot. He or she will feel full after 5 to 6 puffs and they can use it later when they feel the urge. The flavors available in the market for Joyetech electronic cigarette are, strawberry, apple, kiwi, etc. It is also used as an impressive tool to throw a style statement at big business meetings, among friends and others.
A senior official from Evaps spoke about the major benefits of using Joyetech electronic cigarette. He said, “It is easy to fight the leading and the preventable death cause with the help of Joyetech electronic cigarette. The cigarette will never affect your lung and is a boon to heart patients. It will also keep your skin glowing. It is a better solution which not only keeps you healthy but even the passive smokers. It will help you spend quality time with your kids and family members where none of the members will be harmed by the smoke.”
Further the spokesperson of the e-cigarette company said, “The best part about electronic cigarettes is, it helps you save money and keep control over your health. After a few days you will experience a change in your health and see the stamina is coming back. The vapors which come out of the electronic cigarette also offer good smell so you will never have an issue with your breath. Moreover, you enjoy healthy and long life.”
The type of e-liquide offered by the company is terrific in a number of ways. It is also known by the name of e liquid, Nicotine Fluid Juice, smoke juice, and many other names. This non nicotine liquid is filled in the cartridges where you can add more liquid when necessary or change the cartridge and liquid both. It can be done either way.
Garcinia Cambogia is brand new natural weight loss method recently discovered and proved as best fat buster supplement. Doctors featured this new method as most exciting breakthrough in weight loss. Garcinia Cambogia, is a fruit commonly grows in south Asia. This fruit has been used for different health purposes for several years. This made Doctors and other health researchers to waste their efforts and reveal the health beneficial properties of this natural product. It has been long recommending different natural alternatives for weight loss. Recently “The Oz show” Dr. Julie Chen discussed about the weight loss properties of the dual action formula Garcinia Cambogia.
Irregular eating habits may cause lots of health problems, one common problem is obesity. Every 8 out of 10 people get unwanted increase in body weight due to overeating. Health specialists have linked the overeating habit with some psychological issues. People in bad mood commonly eat more. This occurs due to the low level of serotonin, which is a hormone responsible for mood swings. Food is one way to trigger the release of serotonin and enhance the mood, but this emotional overeating leads to obesity. Researchers have been working to find out the weight loss properties of natural products. They found that Garcinia Cambogia triggers the release of serotonin, enhances the mood and keeps emotional over eaters away from consuming more food.
Dr. Julie Chen explained the way Garcinia Cambogia Extracts works. The dual action formula fights against the fat by blocking the fat cells formation and suppressing the bad appetite for food. HCA (Hydroxycitric acid) is the compound which makes this natural product highly effective against excess fat. As the main ingredient of Garcinia Cambogia, HCA changes the way liver converts sugar into fat. It makes the liver convert sugar directly into energy rather than converting it into fat. In this way, it blocks the fat formation process in the body. The excess fat stored in the
body is burned effectively by supercharging the metabolic activity. By suppressing appetite, it eliminates all bad food cravings and develops a healthy eating habit.